Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamax Plus vs Calcitriol in Chinese Postmenopausal Women with Osteoporosis
NCT01350934Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2011
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, open-label trial of alendronate + cholecalciferol in postmenopausal osteoporosis (2 arms), sponsored by Organon & Co. Primary endpoint: Percentage Change From Baseline in Lumbar Spine Bone Mineral Density at 12 months. Started Jun 2011; status: completed.
02
Drugs
alendronate + cholecalciferol
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01350934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350934.